Market Outlook and Recommendations
The SET Index is expected to move sideways up, with the resistance at 1,597/1,605 points and the support at 1,580/1,573 points. Positive momentum...
86 Views
𝛼SK or SearchENTITY
Biogen Inc (BIIB US)
Biogen Inc (BIIB US)
153
Analysis
Health Care • United States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
morex